| scholarly article | Q13442814 |
| P50 | author | Angus W. Thomson | Q29887918 |
| P2093 | author name string | H Hackstein | |
| S C Watkins | |||
| L D Falo | |||
| A E Morelli | |||
| A T Larregina | |||
| A J Logar | |||
| R W Ganster | |||
| G D Papworth | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| dendritic cell | Q506253 | ||
| P304 | page(s) | 7053-62 | |
| P577 | publication date | 2001-06-15 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells | |
| P478 | volume | 166 |
| Q45237091 | A new carboxamide compound exerts immuno-suppressive activity by inhibiting dendritic cell maturation |
| Q53311604 | Additive effects of rapamycin and aspirin on dendritic cell allostimulatory capacity. |
| Q78804319 | Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10 |
| Q35615917 | Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells |
| Q28192370 | Aspirin differentially regulates endotoxin-induced IL-12 and TNF-alpha production in human dendritic cells |
| Q39608385 | Aspirin regulates SNARE protein expression and phagocytosis in dendritic cells |
| Q34082180 | Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway |
| Q28199779 | Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells |
| Q38453650 | Avoiding immunological rejection in regenerative medicine. |
| Q35947888 | Complete remission of human parvovirus b19 associated symptoms by loxoprofen in patients with atopic predispositions |
| Q28080920 | Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus |
| Q28165892 | Control of COX-2 and iNOS gene expressions by aspirin and salicylate |
| Q35116303 | Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? |
| Q42818114 | Cytokine production by dendritic cells genetically engineered to express IL-4: induction of Th2 responses and differential regulation of IL-12 and IL-23 synthesis |
| Q21284774 | Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation |
| Q37754644 | Dendritic cell-based therapy in Type 1 diabetes mellitus |
| Q35756961 | Dendritic cells and autoimmunity |
| Q36425922 | Dendritic cells as promoters of transplant tolerance |
| Q37942858 | Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques |
| Q35161161 | Dendritic cells, T cell tolerance and therapy of adverse immune reactions |
| Q34740521 | Dendritic cells, tolerance induction and transplant outcome |
| Q35620073 | Dendritic cells: emerging pharmacological targets of immunosuppressive drugs |
| Q35583516 | Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction |
| Q34319943 | Designer dendritic cells for tolerance induction: guided not misguided missiles |
| Q35146556 | Designing the optimal vaccine: the importance of cytokines and dendritic cells. |
| Q43261393 | Diclofenac sodium inhibits NFkappaB transcription in osteoclasts |
| Q36429819 | Drinking a lot is good for dendritic cells |
| Q83358537 | Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells |
| Q43428738 | Epigallocatechin gallate modulates cytokine production by bone marrow-derived dendritic cells stimulated with lipopolysaccharide or muramyldipeptide, or infected with Legionella pneumophila |
| Q44031002 | Fisetin Inhibits Lipopolysaccharide-Induced Macrophage Activation and Dendritic Cell Maturation |
| Q35093120 | Functional modulation of dendritic cells to suppress adaptive immune responses |
| Q37773272 | Future therapeutics for the induction of peripheral immune tolerance in autoimmune disease and organ transplantation |
| Q37421622 | GR-independent down-modulation on GM-CSF bone marrow-derived dendritic cells by the selective glucocorticoid receptor modulator Compound A. |
| Q33551489 | IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells |
| Q44016473 | Imaging secretory vesicles by fluorescent protein insertion in propeptide rather than mature secreted peptide |
| Q34842360 | Immature, but not inactive: the tolerogenic function of immature dendritic cells |
| Q36593774 | Immune privilege induced by regulatory T cells in transplantation tolerance |
| Q36897372 | Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus |
| Q27481382 | In vitro atrazine exposure affects the phenotypic and functional maturation of dendritic cells |
| Q40285054 | In vivo characterization of inflammatory biomarkers in swine and the impact of flunixin meglumine administration |
| Q37766241 | Induction of pathogenic cytotoxic T lymphocyte tolerance by dendritic cells: a novel therapeutic target. |
| Q35216487 | Influence of immunosuppressive drugs on dendritic cells |
| Q28221643 | Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches |
| Q38584773 | Interleukin-10 secretion differentiates dendritic cells from human liver and skin |
| Q37348282 | Lead effects on development and function of bone marrow-derived dendritic cells promote Th2 immune responses |
| Q46422409 | Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections |
| Q33356253 | Macropinocytosis is decreased in diabetic mouse macrophages and is regulated by AMPK. |
| Q47384056 | Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells |
| Q36093861 | Monocyte-Derived Dendritic Cells Upregulate Extracellular Catabolism of Aggregated Low-Density Lipoprotein on Maturation, Leading to Foam Cell Formation |
| Q28195487 | Non-steroidal and steroidal anti-inflammatory drugs vary in their modulation of dendritic cell function in the elicitation phase of allergic contact dermatitis |
| Q36592640 | Nonsteroidal Anti-Inflammatory Drugs Quickly Resolve Symptoms Associated with EBV-Induced Infectious Mononucleosis in Patients with Atopic Predispositions. |
| Q46309290 | Nonsteroidal anti-inflammatory drugs do not interfere with imiquimod treatment for usual type vulvar intraepithelial neoplasia |
| Q74681820 | Normal donor bone marrow is superior to Flt3 ligand-mobilized bone marrow in prolonging heart allograft survival when combined with anti-CD40L (CD154) |
| Q37809070 | Novel Findings in Drug-Induced Dendritic Cell Tolerogenicity |
| Q48681818 | Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets |
| Q38237328 | Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease |
| Q28200149 | Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine |
| Q35216477 | Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells |
| Q40965563 | Prospectively defined murine mesenchymal stem cells inhibit Klebsiella pneumoniae-induced acute lung injury and improve pneumonia survival |
| Q26866216 | Regulatory dendritic cells for immunotherapy in immunologic diseases |
| Q26779405 | Role of Dendritic Cells in the Induction of Lymphocyte Tolerance |
| Q38455697 | Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice |
| Q47603279 | Synthesis, acute toxicity and anti-inflammatory effect of bornyl salicylate, a salicylic acid derivative |
| Q27687098 | Targeting dendritic cell function during systemic autoimmunity to restore tolerance |
| Q46161195 | The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice |
| Q59034566 | Therapeutic doses of nonsteroidal anti-inflammatory drugs inhibit osteosarcoma MG-63 osteoblast-like cells maturation, viability, and biomineralization potential |
| Q39069841 | Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? |
| Q37077325 | Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs. |
| Q36473648 | Toward a core nutraceutical program for cancer management |
| Q51041298 | Uremia impairs blood dendritic cell function in hemodialysis patients. |
| Q38553215 | Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases |
| Q35556119 | Why are dendritic cells important in allergic diseases of the respiratory tract? |
Search more.